174 related articles for article (PubMed ID: 16288490)
21. The efficacy of delayed surgery in children with high-risk neuroblastoma.
Varan A; Kesik V; Şenocak ME; Kale G; Akyüz C; Büyükpamukçu M
J Cancer Res Ther; 2015; 11(2):268-71. PubMed ID: 26148582
[TBL] [Abstract][Full Text] [Related]
22. Value of surgical resection in children with high-risk neuroblastoma.
Englum BR; Rialon KL; Speicher PJ; Gulack B; Driscoll TA; Kreissman SG; Rice HE
Pediatr Blood Cancer; 2015 Sep; 62(9):1529-35. PubMed ID: 25810376
[TBL] [Abstract][Full Text] [Related]
23. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
[TBL] [Abstract][Full Text] [Related]
24. The impact of gross total resection on survival in children with stage III/IV neuroblastoma--study of clinical efficacy in 21 cases.
Liu ZL; Xiao YH; Chen DX; Wang Z
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2253-7. PubMed ID: 25219822
[TBL] [Abstract][Full Text] [Related]
25. Experience with aortic grafting during excision of large abdominal neuroblastomas in children.
Paran TS; Corbally MT; Gross-Rom E; Rutigliano DN; Kayton ML; La Quaglia MP
J Pediatr Surg; 2008 Feb; 43(2):335-40. PubMed ID: 18280285
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study.
Yamada S; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Inoshita N; Ito J
J Neurosurg Pediatr; 2018 Jun; 21(6):549-562. PubMed ID: 29600905
[TBL] [Abstract][Full Text] [Related]
27. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.
Chamberlain RS; Quinones R; Dinndorf P; Movassaghi N; Goodstein M; Newman K
Ann Surg Oncol; 1995 Mar; 2(2):93-100. PubMed ID: 7728576
[TBL] [Abstract][Full Text] [Related]
28. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis.
Simon T; Häberle B; Hero B; von Schweinitz D; Berthold F
J Clin Oncol; 2013 Feb; 31(6):752-8. PubMed ID: 23284039
[TBL] [Abstract][Full Text] [Related]
29. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
30. The clinical management and outcomes of cervical neuroblastic tumors.
Jackson JR; Tran HC; Stein JE; Shimada H; Patel AM; Marachelian A; Kim ES
J Surg Res; 2016 Jul; 204(1):109-13. PubMed ID: 27451875
[TBL] [Abstract][Full Text] [Related]
31. The optimal timing of surgical resection in high-risk neuroblastoma.
Rojas Y; Jaramillo S; Lyons K; Mahmood N; Wu MF; Liu H; Vasudevan SA; Guillerman RP; Louis CU; Russell HV; Nuchtern JG; Kim ES
J Pediatr Surg; 2016 Oct; 51(10):1665-9. PubMed ID: 27318861
[TBL] [Abstract][Full Text] [Related]
32. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
[TBL] [Abstract][Full Text] [Related]
33. Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
Garaventa A; Boni L; Lo Piccolo MS; Tonini GP; Gambini C; Mancini A; Tonegatti L; Carli M; di Montezemolo LC; Di Cataldo A; Casale F; Mazzocco K; Cecchetto G; Rizzo A; Bernardi B;
Ann Oncol; 2002 Jun; 13(6):956-64. PubMed ID: 12123342
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.
Adkins ES; Sawin R; Gerbing RB; London WB; Matthay KK; Haase GM
J Pediatr Surg; 2004 Jun; 39(6):931-6. PubMed ID: 15185228
[TBL] [Abstract][Full Text] [Related]
35. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
London WB; Bagatell R; Weigel BJ; Fox E; Guo D; Van Ryn C; Naranjo A; Park JR
Cancer; 2017 Dec; 123(24):4914-4923. PubMed ID: 28885700
[TBL] [Abstract][Full Text] [Related]
36. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
37. Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma.
Browne M; Kletzel M; Cohn SL; Seshadri R; Reynolds M
J Pediatr Surg; 2006 Jan; 41(1):271-6. PubMed ID: 16410146
[TBL] [Abstract][Full Text] [Related]
38. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
[TBL] [Abstract][Full Text] [Related]
39. Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?
Zwaveling S; Tytgat GA; van der Zee DC; Wijnen MH; Heij HA
Pediatr Surg Int; 2012 Oct; 28(10):953-9. PubMed ID: 22722825
[TBL] [Abstract][Full Text] [Related]
40. The role of surgery in the management of stage IV neuroblastoma: a single institution study.
Shorter NA; Davidoff AM; Evans AE; Ross AJ; Zeigler MM; O'Neill JA
Med Pediatr Oncol; 1995 May; 24(5):287-91. PubMed ID: 7700179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
